Related Experiment Video
Updated: Jan 30, 2026

A Possible Zebrafish Model of Polycystic Kidney Disease: Knockdown of wnt5a Causes Cysts in Zebrafish Kidneys
Published on: December 2, 2014
Identifying patient-important outcomes in polycystic kidney disease: An international nominal group technique study
Yeoungjee Cho1,2,3, Benedicte Sautenet4, Talia Gutman5,6
1Department of Nephrology, Princess Alexandra Hospital.
Insights
Patients with autosomal dominant polycystic kidney disease (ADPKD) prioritize kidney function, delayed end-stage kidney disease, and survival. These outcomes focus on maintaining normality and control, improving trial relevance for ADPKD care.
Area of Science:
- Nephrology
- Patient-Reported Outcomes
- Clinical Trial Design
Background:
- Autosomal dominant polycystic kidney disease (ADPKD) significantly increases mortality and morbidity, impacting quality of life.
- Patient-centered outcomes are crucial for shared decision-making but are inconsistently reported in ADPKD trials.
Purpose of the Study:
- To identify and prioritize outcomes that are important to patients with ADPKD and their caregivers.
- To understand the underlying reasons for these outcome priorities in ADPKD research.
Main Methods:
- A nominal group technique was employed with 154 participants (121 patients, 33 caregivers) across Australia, France, and South Korea.
- Participants identified, ranked, and discussed outcomes, with importance scores calculated and thematic analysis conducted.
Main Results:
- The top 10 outcomes included kidney function, end-stage kidney disease, survival, cyst size/growth, cyst pain/bleeding, blood pressure, ability to work, cerebral aneurysm/stroke, mobility/physical function, and fatigue.
- Key themes identified were 'threatening semblance of normality,' 'inability to control,' and 'making sense of diverse risks.'
Conclusions:
- Kidney function, delayed progression to end-stage kidney disease, and survival are paramount for ADPKD patients and caregivers.
- Incorporating these patient-prioritized outcomes can enhance the meaning and clinical relevance of ADPKD trials.
Aim:
Patients with autosomal dominant polycystic kidney disease (ADPKD) are at increased risk of premature mortality, morbidities and complications, which severely impair quality of life. However, patient-centered outcomes are not consistently reported in trials in ADPKD, which can limit shared decision-making. We aimed to identify outcomes important to patients and caregivers and the reasons for their priorities.
Methods:
Nominal group technique was adopted involving patients with ADPKD and caregivers who were purposively selected from eight centres across Australia, France and the Republic of Korea. Participants identified, ranked and discussed outcomes for trials in ADPKD. We calculated an importance score (0-1) for each outcome and conducted thematic analyses.
Results:
Across 17 groups, 154 participants (121 patients, 33 caregivers) aged 19 to 78 (mean 54.5 years) identified 55 outcomes. The 10 highest ranked outcomes were: kidney function (importance score 0.36), end-stage kidney disease (0.32), survival (0.21), cyst size/growth (0.20), cyst pain/bleeding (0.18), blood pressure (0.17), ability to work (0.16), cerebral aneurysm/stroke (0.14), mobility/physical function (0.12), and fatigue (0.12). Three themes were identified: threatening semblance of normality, inability to control and making sense of diverse risks.
Conclusion:
For patients with ADPKD and their caregivers, kidney function, delayed progression to end-stage kidney disease and survival were the highest priorities, and were focused on achieving normality, and maintaining control over health and lifestyle. Implementing these patient-important outcomes may improve the meaning and relevance of trials to inform clinical care in ADPKD.
More Related Videos
12:47Spectral Karyotyping to Study Chromosome Abnormalities in Humans and Mice with Polycystic Kidney Disease
Published on: February 3, 2012
07:35Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
Published on: June 23, 2015
Related Concept Videos
Internal Anatomy of the Kidney
Anatomical Position and Dimensions
The kidneys are retroperitoneal organs positioned against the posterior abdominal wall on either side of the spine, roughly between the twelfth thoracic and third lumbar vertebrae. Each kidney is typically 10-12 cm long, 5-6 cm wide, and 3-4 cm thick, weighing about 150 grams.
Renal Cortex
The outermost region of the kidney is the...
Chronic Kidney Disease I: Introduction
Transformers with Off-Nominal Turns Ratios
Chronic Kidney Disease II: Clinical Manifestations
Imaging Studies I: Kidney, Ureter, and Bladder Studies
Chronic Kidney Disease III: Interprofessional Care